Clinical implications of enzyme induction.
D000438:Alcohols / Q000652:urine; D000654:Amobarbital / Q000627:therapeutic use; D000818:Animals; D000983:Antipyrine / Q000097:blood / Q000627:therapeutic use; D001552:Benzazepines / Q000627:therapeutic use; D001777:Blood Coagulation / Q000187:drug effects; D002697:Chloral Hydrate / Q000627:therapeutic use; D002707:Chlordiazepoxide / Q000627:therapeutic use; D004790:Enzyme Induction; D000431:Ethanol / Q000494:pharmacology; D005470:Fluorometry; D006207:Half-Life; D006801:Humans; D006854:Hydrocortisone / Q000652:urine; D006993:Hypnotics and Sedatives / Q000494:pharmacology* / Q000627:therapeutic use; D007659:Ketones / Q000627:therapeutic use; D007700:Kinetics; D008297:Male; D008660:Metabolism / Q000187:drug effects; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D009019:Morphinans / Q000378:metabolism; D009574:Nitro Compounds / Q000627:therapeutic use; D010243:Paralysis / Q000139:chemically induced; D010634:Phenobarbital / Q000097:blood; D051381:Rats; D012214:Rheumatic Heart Disease / Q000188:drug therapy; D012631:Secobarbital / Q000627:therapeutic use; D012890:Sleep / Q000187:drug effects; D013997:Time Factors; D014859:Warfarin / Q000097:blood / Q000378:metabolism* / Q000652:urine
D000438:Alcohols; D001552:Benzazepines; D006993:Hypnotics and Sedatives; D007659:Ketones; D009019:Morphinans; D009574:Nitro Compounds; D012631:Secobarbital; D000431:Ethanol; D002697:Chloral Hydrate; D014859:Warfarin; D002707:Chlordiazepoxide; D000654:Amobarbital; D000983:Antipyrine; D006854:Hydrocortisone; D010634:Phenobarbital